Skip to main content
. Author manuscript; available in PMC: 2016 Jan 7.
Published in final edited form as: ACS Biomater Sci Eng. 2015 Oct 20;1(12):1300–1305. doi: 10.1021/acsbiomaterials.5b00356

Table 1.

Nomenclature and Composition of Hemostatic Materials Used in This Study

material concentration
hemostat mechanism of clotting
peptide (wt %) batroxobin (μg/mL)
SB5 1   5 batroxobin physical and biochemical hemostat
SB50 1 50 batroxobin physical and biochemical hemostat
SLac 1   0 N/A physical barrier
Bax 0   5 batroxobin cleaves fibrin peptide A
Bax50 0 50 batroxobin cleaves fibrin peptide A
T1 0   0 thrombin (25 μg/mL) intrinsic pathway/extrinsic pathway